Skip to main content
SpringerLink
Log in

Treatment of multi-drug-resistant tuberculosis

  • Chapter
Tuberculosis

  • 208 Accesses

Abstract

Tuberculosis (TB) infections were chronicled by ancient Greek physicians as phthisis in describing the cough, fever and wasting character of this disease. TB did not become a major problem until the industrial revolution when urban overcrowding led to an increase in cases [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Des Prez, R.M. and Heim, C.R. (1990) Mycobacterium tuberculosis, in Principles and Practices of Infectious Diseases (eds G.L. Mandell, R.D. Douglas and J.E. Bennett), Churchill Livingstone, New York, pp. 1877–906.

    Google Scholar 

  2. Holmberg, S.D. (1990) The rise of tuberculosis in America before 1820. Am Rev Respir Dis, 142, 1228–32.

    Article  PubMed  CAS  Google Scholar 

  3. Youmans, G.P., Williston, E.H., Feldman, W.H. and Hinshaw, H.L. (1946) Increase in resistance of tubercle bacilli to streptomycin: Preliminary report. Proc Staff Meet Mayo Clinic, 21, 126–7.

    CAS  Google Scholar 

  4. Pyle, M.M. (1947) Relative numbers of resistant tubercle bacilli in sputa of patients before and after treatment with streptomycin. Proc Staff Meet Mayo Clinic, 22, 465–73.

    CAS  Google Scholar 

  5. Toman, K. (1979) Chemotherapy, in Tuberculosis Case-Finding and Chemotherapy, World Health Organization, Geneva, pp. 75–93.

    Google Scholar 

  6. Brudney, K. and Dobkin, J. (1991) Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness and the decline of tuberculosis control programs. Am Rev Respir Dis, 144, 745–9.

    Article  PubMed  CAS  Google Scholar 

  7. Doster, B.D., Casas, G.J. and Snider, D.E. (1976) A continuing survey of primary drug resistance in tuberculosis, 1961 to 1968. Am Rev Respir Dis, 113, 419–25.

    PubMed  CAS  Google Scholar 

  8. Zeidberg, L.D., Gass, R.S., Dillion, A. et al. (1963) The Williamson County tuberculosis study. A twenty-four-year epidemiologic study. Am Rev Respir Dis, 87, 1–88.

    PubMed  Google Scholar 

  9. Kopanoff, D.E., Kilburn, J.O., Glassroth, J.L. et al. (1978) A continuing survey of primary drug resistance in the United States: March 1975 to November 1977. Am Rev Respir Dis,118, 835–42.

    PubMed  CAS  Google Scholar 

  10. Byrd, R.B., Fisk, D.E., Roethe, R.A. et al. (1979) Tuberculosis in Oriental immigrants: A study in military dependents. Chest, 76, 136–9.

    Article  PubMed  CAS  Google Scholar 

  11. Centers for Disease Control (1983) Primary resistance to antituberculosis drugs — United States. MMWR, 32, 521–3.

    Google Scholar 

  12. Snider, D.E., Cauthen, G.M., Farer, L.S. et al. (1991) Drug-resistant tuberculosis. Am Rev Respir Dis, 144, 732.

    Article  PubMed  Google Scholar 

  13. Ben-Dov, I. and Mason, G.R. (1987) Drug-resistant tuberculosis in a Southern California hospital. Trends from 1969 to 1984. Am Rev Respir Dis,135, 1307–10.

    PubMed  CAS  Google Scholar 

  14. Steiner, P., Rao, M., Victoria, M.S. et al. (1983) A continuing study of primary drug-resistant tuberculosis among children observed at Kings County Hospital Medical Center between the years 1961 and 1980. Am Rev Respir Dis, 128, 425–8.

    PubMed  CAS  Google Scholar 

  15. Freiden, T.R., Sterling, T., Ariel, P.M. et al. (1993) The emergence of drug-resistant tuberculosis in New York City. N Engl J Med, 328, 521–6.

    Article  Google Scholar 

  16. Weymouth, L.A., Kaminski, D.A., Vonbuskirk, R.L. and Hyde, R.W. (1992) Change in drug resistance patterns of Mycobacterium tuberculosis in Rochester, New York. Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, CA, American Society for Microbiology.

    Google Scholar 

  17. Centers for Disease Control (1990) Tuberculosis morbidity in the United States: final data. MMWR, 40 (SS-3), 23–7.

    Google Scholar 

  18. Kleeberg, H. and Oliver, M. (1984) A World Atlas of Initial Drug Resistance, Tuberculosis Research Institute of the South African Medical Research Council (MRC), Pretoria, South Africa.

    Google Scholar 

  19. Scalicini, M., Carre, G., Jean-Daptisue, M. et al. (1990) Antituberculous drug resistance in Central Haiti. Am Rev Respir Dis, 142, 508–11.

    Article  Google Scholar 

  20. Rodier, G., Gravier, P., Sevre, J. et al. (1993) Multidrug-resistant tuberculosis in the Horn of Africa. J Infect Dis, 168, 523–4.

    Article  PubMed  CAS  Google Scholar 

  21. Hong Kong Chest Service/British Medical Research Council (1987) Five-year follow-up of a controlled trial of five 6 month regimes of chemotherapy for pulmonary tuberculosis. Am Rev Respir Dis, 136, 1339–42.

    Article  Google Scholar 

  22. Mitchison, D. and Nunn, A. (1986) Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis, 133, 423–30.

    PubMed  CAS  Google Scholar 

  23. McClatchy, J.K., Kane, S.W., Davidson, P.R. et al. (1977) Cross-resistance in M. tuberculosis to kanamycin, capreomycin and viomycin. Tubercle, 58, 29–34.

    Article  PubMed  CAS  Google Scholar 

  24. Simone, P.M. and Iseman, M.D. (1992) Drug-resistant tuberculosis: A deadlyand-growing-danger. J Respir Dis, 13, 960–71.

    Google Scholar 

  25. Stead, W.W., To, T., Harrison, R.W. and Abraham, J.H. (1987) Benefit-risk considerations in preventive treatment for tuberculosis in elderly persons. Ann Intern Med, 107, 843–5.

    Article  PubMed  CAS  Google Scholar 

  26. Mandell, G.L. and Sande, M.A. (1990) Drugs used in the chemotherapy of tuberculosis and leprosy, in Goodman and Gilman’s The Pharmacologic Basis of Therapeutics (eds A.G. Gilman, T.W. Rall, A.S. Nies and P. Taylor), Pergamon Press, New York, pp. 1146–62.

    Google Scholar 

  27. Yew, W.W., Wong, C.F., Wong, P.C. et al. (1993) Adverse neurological reactions in patients with multidrug-resistant pulmonary tuberculosis after coadministration of cycloserine and ofloxacin. Clin Infect Dis,17, 288–9.

    Article  PubMed  CAS  Google Scholar 

  28. Iseman, M.D. (1993) Treatment of multidrug-resistant tuberculosis. New Engl J Med, 329, 784–91.

    Article  PubMed  CAS  Google Scholar 

  29. Iseman, M.D., Madsen, L., Goble, M. and Pomerantz, M. (1990) Surgical intervention in the treatment of pulmonary disease caused by drug-resistant Mycobacterium tuberculosis. Am Rev Respir Dis, 141, 623–5.

    Article  CAS  Google Scholar 

  30. Goble, M.J., Iseman, M., Madsen, L.A. et al. (1993) Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. New Engl J Med, 328, 527–32.

    Article  PubMed  CAS  Google Scholar 

  31. Di Perri, G., Crucian, M., Danz, M.C. et al. (1989) Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet, 2, 1502–4.

    PubMed  Google Scholar 

  32. Fischl, M.A., Uttamchandani, R.B., Daikos, G.L. et al. (1992) An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection. Ann Intern Med, 117, 177–83.

    Article  PubMed  CAS  Google Scholar 

  33. Daley, C.L., Small, P.M., Schecter, G.F. et al. (1992) An outbreak of tuberculosis with accelerated progression among persons infected with human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med, 326, 231–5.

    Article  PubMed  CAS  Google Scholar 

  34. Centers for Disease Control (1991) Tuberculosis outbreak among persons in a residential facility for HIV-infected persons — San Francisco. MMWR, 40, 649–52.

    Google Scholar 

  35. Fischl, M.A., Daikos, G.L., Uttamchandani, R.B. et al. (1992) Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple drug-resistant bacilli. Ann Intern Med, 117, 184–90.

    Article  PubMed  CAS  Google Scholar 

  36. Edlin, B.R., Attoe, L.S., Grieco, M.H. et al. (1993) Recognition and treatment of primary multidrug-resistant tuberculosis (MDRTB) in HIV-infected patients. IXth International Conference on AIDS, Berlin, World Health Organization.

    Google Scholar 

  37. Lockhart, B., Sharp, V., Squires, K. et al. (1993) Improved outcome of MDR-TB in patients receiving a five or more drug initial therapy. IXth International Conference on AIDS, Berlin, World Health Organization.

    Google Scholar 

  38. Stroud, L., Tokars, J., Grieco, M. et al. (1993) Interrruption of Nosocomial Transmission of Multi-drug Resistant Mycobacterium tuberculosis in a New York City Hospital. Society of Hospital Epidemiologists of America, Chicago, IL.

    Google Scholar 

  39. Wenger, P., Beck-Sague, C., Otten, J. et al. (1993) Efficacy of Control Measures in Preventing Nosocomial Transmission of Multi-drug Resistant Mycobacterium tuberculosis among Patients and Health Care Workers. Society of Hospital Epidemiologists of America, Chicago, IL.

    Google Scholar 

  40. Ferebee, S.H. (1970) Controlled chemoprophylaxis trials in tuberculosis: A general review. Adv Tuberc Res, 17, 28–106.

    Google Scholar 

  41. American Thoracic Society/CDC (1986) Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis, 134, 355–63.

    Google Scholar 

  42. Comstock, G.W., Liversay, V.T. and Woolpert, S.F. (1974) The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol, 99, 131–8.

    PubMed  CAS  Google Scholar 

  43. International Union Against Tuberculosis, Committee on Prophylaxis (1982) Efficacy of various durations of isoniazid preventive therapy for tuberculosis: Five years of follow-up in the IUAT trial. Bull WHO, 60, 555–64.

    Google Scholar 

  44. Fairshter, R.D., Randazzo, G.P., Garlin, J. and Wilson, A.F. (1975) Failure of isoniazid prophylaxis after exposure to isoniazid-resistant tuberculosis. Am Rev Respir Dis,112, 37–43.

    PubMed  CAS  Google Scholar 

  45. Centers for Disease Control (1992) National action plan to combat multidrugresistant tuberculosis. MMWR, 41 (RR-11), 1–45.

    Google Scholar 

  46. Lecoeur, H.F., Truffot-Pernot, C. and Grosset, J.H. (1989) Experimental short course preventive therapy of tuberculosis with rifampin and pyrazinamide. Am Rev Respir Dis, 140, 1189–93.

    Article  PubMed  CAS  Google Scholar 

  47. Croule, A.J., Sbarbaro, J.A., Judson, F.N. and May, M.H. (1985) The effect of ethambutol on tubercle bacilli within cultured human macrophages. Am Rev Respir Dis,132, 742–5.

    Google Scholar 

  48. Gorzynski, E.A., Gutman, S.I. and Allen, W. (1989) Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, perfloxacin, reference fluoroquinolones, and a new macrolide clarithromycin. Antimicrob Agents Chemother, 33, 591–2.

    Article  PubMed  CAS  Google Scholar 

  49. Horn, D.L., Hewlett, D., Alfalla, C. et al. (1994) Limited tolerance of ofloxacin and pyrazinamide prophylaxis against tuberculosis. N Engl J Med, 330, 1241.

    Article  PubMed  CAS  Google Scholar 

  50. Dooley, S.W., Jarvis, W.R., Martone, W.J. and Snider, D.E. (1992) Multidrugresistant tuberculosis. Ann Intern Med, 117, 257–8.

    Article  PubMed  CAS  Google Scholar 

  51. Brudney, K. and Dobkin, J. (1991) A tale of two cities: Tuberculosis control in Nicaragua and New York City. Semin Resp Infect, 6, 261–72.

    CAS  Google Scholar 

  52. Pearson, M.L., Jereb, J.A., Frieden, T.R. et al. (1992) Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis: a risk to patients and health care workers. Ann Intern Med, 117, 191–6.

    Article  PubMed  CAS  Google Scholar 

  53. Centers for Disease Control (1990) Nosocomial transmission of multidrugresistant tuberculosis to the health care workers and HIV-infected patients in an urban hospital — Florida. MMWR, 39, 718–22.

    Google Scholar 

  54. Centers for Disease Control (1991) Nosocomial transmission of multidrugresistant tuberculosis among HIV-infected persons — Florida and New York, 1988–1991. MMWR, 40, 585–91.

    Google Scholar 

  55. Edlin, B.R., Tokars, J.I., Grieco, M.H. et al. (1992) Nosocomial transmission of multidrug-resistant tuberculosis among AIDS patients: Epidemiologic studies and restriction fragment length polymorphism analysis. N Engl J Med, 326, 1514–21.

    Article  PubMed  CAS  Google Scholar 

  56. Reves, R., Blakey, D., Snider, D.E. and Farer, L.S. (1981) Transmission of multiple drug-resistant tuberculosis: report of a school and community outbreak. Am J Epidemiol, 113, 423–35.

    PubMed  CAS  Google Scholar 

  57. Centers for Disease Control (1987) Outbreak of multidrug-resistant tuberculosis — North Carolina. MMWR, 35, 785–7.

    Google Scholar 

  58. Centers for Disease Control (1990) Outbreak of multidrug-resistant tuberculosis — Texas, California, and Pennsylvania. MMWR, 39, 369–72.

    Google Scholar 

  59. Nardell, E., McInnis, B., Thomas, B. and Weidhass, D. (1986) Exogenous reinfection with tuberculosis in a shelter for the homeless. N Engl J Med, 315, 1570–5.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Livette S. Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kent A. Sepkowitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Larry I. Lutwick

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Johnson, L.S., Sepkowitz, K.A. (1995). Treatment of multi-drug-resistant tuberculosis. In: Lutwick, L.I. (eds) Tuberculosis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2869-6_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-2869-6_13

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-412-60740-0

  • Online ISBN: 978-1-4899-2869-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation